HIFU is FDA-approved for treating uterine fibroids, prostate cancer, and essential tremors, with devices like Insightec's Exablate Neuro leading adoption. A 2024 JAMA Surgery study found that HIFU ...

The ExAblate Neuro System, developed by InSightec in Tirat Carmel, Israel, was utilized for performing a unilateral MR-guided focused ultrasound (MRgFUS) thalamotomy targeting the VIM contralateral to ...

Chicago, April 23, 2025 (GLOBE NEWSWIRE) -- The global ultrasound devices market was valued at US$ 9.35 billion in 2024 and is anticipated to reach US$ 14.18 billion by 2033, growing at a CAGR of ...